This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
On February 15, 2023, the Federal Circuit (“CAFC”) affirmed a summary judgment ruling that, by merely showcasing an embodying device at an industry event (the “Event”), Minerva Surgical, Inc. Minerva”) had engaged in an invalidating publicuse more than one year before its patent filing. . By: Irwin IP LLP
PatKat reviewing the year It is time once more for the IPKat patent year in review! The topic of prior use has been elevated to the status of a referral to the Enlarged Board of Appeal ( G1/23 ). At the very least, LLMs have substantially lessened the burden of sourcing cat-themed patent blog illustrations.
In a noteworthy year for patent law, the U.S. Court of Appeals for the Federal Circuit issued several decisions that will shape the patent landscape and the Federal Rules of Evidence governing expert testimony were amended. Supreme Court and the U.S. By: Smith Anderson
2021-2246] (February 15, 2023), the Federal Circuit affirmed summary judgment that the asserted claims of U.S. 9,186,208 on surgical devices for a procedure called endometrial ablation were anticipated under the publicuse bar of pre-AIA 35 U.S.C. § In Minerva Surgical, Inc. Hologic, Inc., By: Harness IP
The case at issue concerned European patent EP2950075 , owned by Horiba Ltd, relating to an on-road running exhaust gas test apparatus. The patent claimed an apparatus for vehicle exhaust gas testing comprising an information processing unit connected to a display that could acquire and process running data during road tests.
Kaijet highlights the narrowness of the pre-filing grace period (safe harbor) provision under the America Invents Act (AIA) and serves as a reminder that there are a number of patents that would have been valid under the pre-AIA patent system may no longer be valid under the current law. 2023-1336 (Fed. Sanho Corp.
Feb 1, 2023, is the new deadline for providing comments to the USPTO on this RFC. Identify any specific sources of prior art not currently available through the Patents End-to-End Search system that you believe examiners should be searching. link] Topics : The USPTO invites written responses to the following questions and requests.
The utility patent at issue covers a petunia plant. Here, the Federal Circuit has affirmed that the claims are invalid based upon a pre-filing trade-show display of the ornamental plant — holding that the display counted as a “publicuse.” The oddity of this utility patent is that it claims an ornamental plant.
The public display of simply a prototype of a patentable technology for marketing purposes, over a year prior to its patenting, is enough to rule that the technology is in publicuse, ready for patenting, and is thus invalid. filed a patent for a medical device called the Aurora. Minerva Surgical Inc.
Its gained momentum with the advent of importance in R&D and patent registration. It’s the first important step towards protecting owner’s rights and its lawful publicuse. The transfer is facilitated in India by the Indian Patent office. Well, it helps in commercialisation of the invention by allowing its publicuse.
2021-2246 ] (February 15, 2023), the Federal Circuit affirmed summary judgment that the asserted claims of U.S. 9,186,208 on surgical devices for a procedure called endometrial ablation were anticipated under the publicuse bar of pre-AIA 35 U.S.C. § Hologic, Inc., § 102(b).
The recent Board of Appeal case T 0209/22 is yet another decision demonstrating the relatively permissive approach in Europe to medical use inventions. The patent related to the medical use of a combination of known drugs. The patent did not include any patient data for the drug combination.
Despite the EPO's continued insistence that the issue is settled ( IPKat ), we can expect the issue to rumble on into 2023. Artificial intelligence is not breaking patent law: EPO publishes DABUS decision (J 8/20) ST.26 26 sequence listings: A forward or backward step for ease of access to patent sequence data? (20 26 ( IPKat ).
Disclosure of Patentable Ideas To figure out if disclosing invention details to ChatGPT is a public disclosure under patent law, we need to see if it can be categorized as a description in a printed publication, publicuse, or public sale. enablement). The court in Hurry Family Revocable Tr.
Disclosure of Patentable Ideas To figure out if disclosing invention details to ChatGPT is a public disclosure under patent law, we need to see if it can be categorized as a description in a printed publication, publicuse, or public sale. enablement). The court in Hurry Family Revocable Tr.
Implications for Patent/Trademark Prosecutors and Holders The U.S. Patent and Trademark Office (USPTO) recently issued guidance on the use of artificial intelligence (AI), particularly generative AI, in Intellectual Property (IP) practices involving documents filed at the USPTO.
Disclosure of Patentable Ideas To figure out if disclosing invention details to ChatGPT is a public disclosure under patent law, we need to see if it can be categorized as a description in a printed publication, publicuse, or public sale. enablement). The court in Hurry Family Revocable Tr.
No earlier than July 31, 2023 per settlement. No earlier than November 20, 2023 per settlement. . No earlier than June 30, 2023 per settlement. No earlier than September 30, 2023 per settlement. No earlier than July 1, 2023 per settlement. No earlier than January 31, 2023 per settlement. January 2021.
It seems that the domestic pressure resulting from their ever-increasing healthcare costs has reached a point where there is finally some re-examination of how their patent system is affecting costs. which requires patented products to be significantly manufactured in the US until it is commercially infeasible.
Copyright infringement appeals are ordinarily not heard by the Federal Circuit, but in a case of what appears to be appellate-forum shopping, SAS had also included patent infringement allegations that they eventually stopped pursuing. WPL demonstrated that the SAS Language should be filtered because it is open and free for publicuse.
How long the descendible right lasts beyond the initial 10-year period depends on continued “authorized publicuse of the voice or visual likeness of the individual.” Post-mortem rights The NO FAKES digital replica right survives the individual for a minimum of life+10 and a maximum of life+70. What about the First Amendment?
Patent and Trademark Office (USPTO) recently published a request for comments addressing a variety of topics related to generic drug and biosimilar competition. Senators sent a letter to the USPTO to consider changes to its regulations and practices to address “patent thickets.”
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content